Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 26-Jun-23 4:05 PM View:  | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 26-Jun-23 | Disposition (change in control) | 31,470 | $9.10 | $286,377.00 | (100%) 31.47K to 0 | |
| 26-Jun-23 4:05 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 26-Jun-23 | Disposition (change in control) | 17,547 | $9.10 | $159,678.00 | (100%) 17.55K to 0 | |
| 26-Jun-23 4:05 PM View: | Perry Matthew D Director | Cell Therapeutics, Inc. (CTIC) | 26-Jun-23 | Disposition (change in control) | 43,139 | $9.10 | $392,565.00 | (100%) 43.14K to 0 | |
| 26-Jun-23 4:05 PM View: | Tuckson Reed Vaughn Director | Cell Therapeutics, Inc. (CTIC) | 26-Jun-23 | Disposition (change in control) | 48,639 | $9.10 | $442,615.00 | (100%) 48.64K to 0 | |
| 28-Jun-23 6:26 PM View: | Bvf Partners L P/il Director 10% Owner | Cell Therapeutics, Inc. (CTIC) | 26-Jun-23 | Disposition (change in control) | 7,286,870 | $9.10 | $66,310,600.00 | (82%) 8.86M to 1.57M | |
| 28-Jun-23 6:26 PM View: | Bvf Partners L P/il Director 10% Owner | Cell Therapeutics, Inc. (CTIC) | 26-Jun-23 | Disposition (change in control) | 1,569,290 | $9.10 | $14,280,500.00 | (100%) 1.57M to 0 | |
| 26-Jun-23 4:05 PM View: | Fong James K EVP & Chief Commercial Officer | Cell Therapeutics, Inc. (CTIC) | 26-Jun-23 | Disposition (change in control) | 3,565 | $9.10 | $32,441.50 | (100%) 3.56K to 0 | |
| 26-Jan-23 4:49 PM View: | Fong James K EVP & Chief Commercial Officer | Cell Therapeutics, Inc. (CTIC) | 24-Jan-23 | Option Exercise | 100,000 | $0.95 | $94,890.00 | 2805% 3.56K to 103.56K | |
| 26-Jan-23 4:49 PM View: | Fong James K EVP & Chief Commercial Officer | Cell Therapeutics, Inc. (CTIC) | 24-Jan-23 | Planned Option Sale | 100,000 | $6.00 | $600,000.00 | (97%) 103.56K to 3.56K | |
| 26-Jan-23 5:17 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 24-Jan-23 | Planned Option Sale | 85,317 | $6.00 | $511,923.00 | (74%) 114.76K to 29.44K | |
| 26-Jan-23 5:17 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 24-Jan-23 | Option Exercise | 85,317 | $0.84 | $71,760.10 | 290% 29.44K to 114.76K | |
| 03-Jan-23 7:47 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 03-Jan-23 | Planned Option Sale | 84,683 | $6.01 | $509,224.00 | (74%) 114.12K to 29.44K | |
| 03-Jan-23 6:36 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 03-Jan-23 | Option Exercise | 27,021 | $0.95 | $25,640.20 | 158% 17.13K to 44.15K | |
| 03-Jan-23 7:47 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 03-Jan-23 | Option Exercise | 84,683 | $0.84 | $71,226.90 | 288% 29.44K to 114.12K | |
| 03-Jan-23 6:36 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 03-Jan-23 | Planned Option Sale | 27,021 | $6.01 | $162,423.00 | (61%) 44.15K to 17.13K | |
| 03-Jan-23 7:47 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 30-Dec-22 | Planned Option Sale | 17,100 | $6.00 | $102,648.00 | (37%) 46.54K to 29.44K | |
| 03-Jan-23 6:36 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 30-Dec-22 | Grant | 214 | $5.11 | $1,093.22 | 1% 16.91K to 17.13K | |
| 03-Jan-23 6:36 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 30-Dec-22 | Option Exercise | 13,847 | $0.95 | $13,139.40 | 81% 17.13K to 30.97K | |
| 03-Jan-23 7:47 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 30-Dec-22 | Option Exercise | 17,100 | $0.84 | $14,382.80 | 58% 29.44K to 46.54K | |
| 03-Jan-23 7:47 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 30-Dec-22 | Grant | 1,579 | $5.11 | $8,066.32 | 6% 27.86K to 29.44K | |
| 03-Jan-23 6:36 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 30-Dec-22 | Planned Option Sale | 13,847 | $6.00 | $83,096.50 | (45%) 30.97K to 17.13K | |
| 03-Jan-23 6:36 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 29-Dec-22 | Planned Option Sale | 13,174 | $6.00 | $79,044.00 | (44%) 30.09K to 16.91K | |
| 03-Jan-23 7:47 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 29-Dec-22 | Planned Option Sale | 13,800 | $6.00 | $82,800.00 | (33%) 41.66K to 27.86K | |
| 03-Jan-23 6:36 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 29-Dec-22 | Option Exercise | 13,174 | $0.95 | $12,500.80 | 78% 16.91K to 30.09K | |
| 03-Jan-23 7:47 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 29-Dec-22 | Option Exercise | 13,800 | $0.84 | $11,607.20 | 50% 27.86K to 41.66K | |
| 14-Feb-23 10:00 PM View: | Tuckson Reed Vaughn Director | Cell Therapeutics, Inc. (CTIC) | 16-Dec-22 | Gift | 43,785 | -- | -- | (47%) 92.42K to 48.64K | |
| 14-Nov-22 4:42 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 10-Nov-22 | Planned Option Sale | 188,304 | $6.00 | $1,130,700.00 | (87%) 216.16K to 27.86K | |
| 14-Nov-22 4:42 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 10-Nov-22 | Option Exercise | 188,304 | $0.84 | $158,382.00 | 676% 27.86K to 216.16K | |
| 14-Nov-22 4:42 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 09-Nov-22 | Option Exercise | 53,996 | $0.84 | $45,416.00 | 194% 27.86K to 81.86K | |
| 14-Nov-22 4:42 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 09-Nov-22 | Planned Option Sale | 53,996 | $6.00 | $324,056.00 | (66%) 81.86K to 27.86K | |
| 10-Nov-22 4:54 PM View: | Metzger Michael A Director | Cell Therapeutics, Inc. (CTIC) | 08-Nov-22 | Option Exercise | 91,500 | $0.95 | $86,971.40 | 100% 0 to 91.5K | |
| 10-Nov-22 4:54 PM View: | Metzger Michael A Director | Cell Therapeutics, Inc. (CTIC) | 08-Nov-22 | Planned Option Sale | 91,500 | $5.58 | $511,019.00 | (100%) 91.5K to 0 | |
| 06-Oct-22 4:20 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 04-Oct-22 | Option Exercise | 2,109 | $0.95 | $2,001.23 | 12% 16.91K to 19.02K | |
| 06-Oct-22 4:20 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 04-Oct-22 | Planned Option Sale | 2,109 | $6.26 | $13,194.40 | (11%) 19.02K to 16.91K | |
| 03-Oct-22 6:26 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 03-Oct-22 | Option Exercise | 300 | $0.95 | $284.67 | 2% 16.91K to 17.21K | |
| 03-Oct-22 6:26 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 03-Oct-22 | Planned Option Sale | 300 | $6.25 | $1,875.00 | (2%) 17.21K to 16.91K | |
| 03-Oct-22 6:26 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 30-Sep-22 | Planned Option Sale | 139,841 | $6.05 | $845,549.00 | (89%) 156.75K to 16.91K | |
| 03-Oct-22 6:26 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 30-Sep-22 | Option Exercise | 139,841 | $0.95 | $132,695.00 | 827% 16.91K to 156.75K | |
| 03-Oct-22 6:26 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 29-Sep-22 | Option Exercise | 900 | $0.95 | $854.01 | 5% 16.91K to 17.81K | |
| 03-Oct-22 6:26 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 29-Sep-22 | Planned Option Sale | 900 | $6.00 | $5,401.00 | (5%) 17.81K to 16.91K | |
| 20-Sep-22 4:59 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 16-Sep-22 | Option Exercise | 22,592 | $0.95 | $21,437.50 | 134% 16.91K to 39.51K | |
| 20-Sep-22 4:59 PM View: | Kirske David EVP, Chief Financial Officer | Cell Therapeutics, Inc. (CTIC) | 16-Sep-22 | Planned Option Sale | 22,592 | $6.02 | $136,004.00 | (57%) 39.51K to 16.91K | |
| 14-Sep-22 4:35 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 12-Sep-22 | Planned Option Sale | 242,300 | $6.43 | $1,557,990.00 | (90%) 270.16K to 27.86K | |
| 14-Sep-22 4:35 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 12-Sep-22 | Option Exercise | 242,300 | $0.84 | $203,799.00 | 870% 27.86K to 270.16K | |
| 16-Aug-22 4:07 PM View: | Craig Adam R President and CEO Director | Cell Therapeutics, Inc. (CTIC) | 16-Aug-22 | Purchase | 5,000 | $5.50 | $27,500.00 | 22% 22.86K to 27.86K | |
| 11-Aug-22 5:52 PM View: | Bvf Partners L P/il Director 10% Owner | Cell Therapeutics, Inc. (CTIC) | 09-Aug-22 | Conversion | 6,863,330 | -- | -- | 76% 8.97M to 15.84M | |
| 11-Aug-22 5:52 PM View: | Bvf Partners L P/il Director 10% Owner | Cell Therapeutics, Inc. (CTIC) | 09-Aug-22 | Sale | 1,289,430 | $6.12 | $7,891,340.00 | (13%) 10.15M to 8.86M | |
| 11-Aug-22 5:52 PM View: | Bvf Partners L P/il Director 10% Owner | Cell Therapeutics, Inc. (CTIC) | 09-Aug-22 | Conversion | 1,520,000 | -- | -- | 10% 15.84M to 17.36M | |
| 11-Aug-22 5:52 PM View: | Bvf Partners L P/il Director 10% Owner | Cell Therapeutics, Inc. (CTIC) | 09-Aug-22 | Sale | 7,210,570 | $6.12 | $44,128,700.00 | (42%) 17.36M to 10.15M | |
| 11-Jul-22 4:51 PM View: | Metzger Michael A Director | Cell Therapeutics, Inc. (CTIC) | 07-Jul-22 | Private Sale (Planned) | 20,121 | $6.51 | $130,995.00 | (100%) 20.12K to 0 |
